Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)
皮下注射曲妥珠单抗/帕妥珠单抗与静脉注射曲妥珠单抗:辅助曲妥珠单抗/帕妥珠单抗治疗I期HER2+乳腺癌II期试验的时间和动作子研究(ADEPT试验)
期刊:Jco Oncology Practice
影响因子:4.6
doi:10.1200/OP.24.00021
Waks, Adrienne G; Chen, Emily L; Graham, Noah; Frey, Anna Mae; Almeida, Kenneth; Attaya, Victoria; Ryding, Cari; Abbass, Ibrahim; Fung, Anita; Sussell, Jesse; Cortazar, Patricia; Harvey, Caroline; Leth, Denise; Faggen, Meredith; Sinclair, Natalie; Walsh, Jeanna; Tung, Nadine; Sinclair, Sarah; Lo, Steve; Yardley, Denise; Valero, Vicente; Meisel, Jane; Ballinger, Tarah J; Adams, Sylvia; Carey, Lisa A; Rauch, Julia K; Abramson, Vandana G; Williams, Nicole O; Chen, Wendy Y; Leone, Jose P; Schumer, Susan T; Tayob, Nabihah; Tolaney, Sara M